17-hydroxyprogesterone caproate for women with congenital uterine anomalies: does it impact the risk of recurrent preterm birth?

Autor: Hynes JS; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Duke University Medical Center, 201 Trent Drive, Durham, NC 27710. Electronic address: jenna.hynes@duke.edu., Schwartz AR; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Duke University Medical Center, 201 Trent Drive, Durham, NC 27710., Abdalla A; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Duke University Medical Center, 201 Trent Drive, Durham, NC 27710., Manuck TA; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of North Carolina School of Medicine, Chapel Hill, NC., Dotters-Katz SK; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC.
Jazyk: angličtina
Zdroj: American journal of obstetrics & gynecology MFM [Am J Obstet Gynecol MFM] 2021 Jan; Vol. 3 (1), pp. 100278. Date of Electronic Publication: 2020 Nov 20.
DOI: 10.1016/j.ajogmf.2020.100278
Databáze: MEDLINE